Literature DB >> 35366201

Comparative efficacy of exercise training processes in improving nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Xue Yu1, Yan Wang1, Jianming Lai1, Ting Song1, Jianping Duan2.   

Abstract

OBJECTIVES: This systematic review and meta-analysis aimed to evaluate the efficacy of exercise training in patients with nonalcoholic fatty liver disease (NAFLD).
METHODS: We searched PubMed, Cochrane Library, Web of Science, and Embase for relevant research from January 2001 to December 2021. The efficacy of exercise training was analyzed.
RESULTS: A total of 21 articles, involving 1733 patients, were included. Exercise training, including resistance training, aerobic exercise training, and high-intensity training, showed the efficacy in reducing weight (MD = 3.46, 95% CI [1.94, 4.98]), BMI (MD = 0.89, 95% CI [0.17, 1.61]), and ALT (MD = 6.66, 95% CI [3.27, 10.04]) and AST (MD = 3.14, 95% CI [0.35, 5.93]) levels in patients with NAFLD. When the exercise training lasted for ≥ 20 weeks, the total cholesterol (TC) (MD = 0.13, 95% CI [0.04, 0.22]), triglyceride (TG) (MD = 0.29, 95% CI [0.12, 0.47]), and blood glucose (GLU) (MD =  - 0.18, 95% CI [0.10, 0.26]) levels significantly reduced. Compared with the exercise training group, the exercise training combined with probiotics group showed more efficiency in reducing the ALT, AST, TG, and TC levels. However, the exercise training combined with a hypoglycemic agent group showed no obvious efficiency compared with the exercise training group.
CONCLUSION: Exercise training can improve NAFLD. The improvement was more obvious when exercise was performed for ≥ 20 weeks. Probiotics may enhance the efficiency of exercise training.
© 2022. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Exercise raining; Meta-analysis; NAFLD

Year:  2022        PMID: 35366201     DOI: 10.1007/s11845-022-02988-x

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  33 in total

1.  Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease.

Authors:  Joan Khoo; John C Hsiang; Ranu Taneja; Seok-Hwee Koo; Gaik-Hong Soon; Carmen J Kam; Ngai-Moh Law; Tiing-Leong Ang
Journal:  Liver Int       Date:  2019-02-24       Impact factor: 5.828

2.  Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases.

Authors:  Jingjing Cai; Xiao-Jing Zhang; Yan-Xiao Ji; Peng Zhang; Zhi-Gang She; Hongliang Li
Journal:  Circ Res       Date:  2020-02-27       Impact factor: 17.367

3.  Long-term effect of exercise on improving fatty liver and cardiovascular risk factors in obese adults: A 1-year follow-up study.

Authors:  Hui-Jie Zhang; Ling-Ling Pan; Zhi-Min Ma; Zheng Chen; Zhu-Feng Huang; Qian Sun; Yan Lu; Cheng-Kun Han; Ming-Zhu Lin; Xue-Jun Li; Shu-Yu Yang; Xiao-Ying Li
Journal:  Diabetes Obes Metab       Date:  2016-11-22       Impact factor: 6.577

4.  Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.

Authors:  Joel E Lavine; Jeffrey B Schwimmer; Mark L Van Natta; Jean P Molleston; Karen F Murray; Philip Rosenthal; Stephanie H Abrams; Ann O Scheimann; Arun J Sanyal; Naga Chalasani; James Tonascia; Aynur Ünalp; Jeanne M Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

5.  Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Ruth Suk-Mei Chan; Sally She-Ting Shu; Bernice Ho-Ki Cheung; Liz Sin Li; Angel Mei-Ling Chim; Carmen Ka-Man Chan; Julie Ka-Yu Leung; Winnie Chiu-Wing Chu; Jean Woo; Henry Lik-Yuen Chan
Journal:  J Hepatol       Date:  2018-08-22       Impact factor: 25.083

Review 6.  Effect of resistant starch type 2 on inflammatory mediators: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Fahimeh Haghighatdoost; Ali Gholami; Mitra Hariri
Journal:  Complement Ther Med       Date:  2020-10-24       Impact factor: 2.446

7.  Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.

Authors:  Farnush Bakhshimoghaddam; Kamran Shateri; Morad Sina; Maryam Hashemian; Mohammad Alizadeh
Journal:  J Nutr       Date:  2018-08-01       Impact factor: 4.798

8.  Simple Resistance Exercise for 24 Weeks Decreases Alanine Aminotransferase Levels in Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Atsushi Takahashi; Hiromichi Imaizumi; Manabu Hayashi; Ken Okai; Kazumichi Abe; Keiji Usami; Nobuo Tanji; Hiromasa Ohira
Journal:  Sports Med Int Open       Date:  2017-01-31

9.  All in the Family: systematic reviews, rapid reviews, scoping reviews, realist reviews, and more.

Authors:  David Moher; Lesley Stewart; Paul Shekelle
Journal:  Syst Rev       Date:  2015-12-22

10.  Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes.

Authors:  Ebrahim Banitalebi; Mohammad Faramarzi; Samira Nasiri; Majid Mardaniyan; Vahid Rabiee
Journal:  Clin Mol Hepatol       Date:  2019-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.